Stepping down safely: deprescribing gabapentinoids in practice

0
Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.

So long SABA, hello ICS/LABA says respiratory expert

0
SABA overuse is undermining asthma control. This National Asthma Week, pharmacists should inform patients about the risks.

What does a Schedule 3 vaping consultation involve?

0
Find out what will be involved in vaping consultations and the documentation that will be required, as experts reveal the details at PSA24.

So you want to be a pharmacist prescriber?

0
This state just made pharmacist prescribing permanent, with others to follow. Here's what pharmacists need to know to embrace this new role.

PBS-backed esketamine rolls out for depression with S8 controls

0
Esketamine will soon be funded for treatment-resistant depression, requiring pharmacists to adhere to strict supply and handling conditions.

The dos and don’ts of advance S3 supply

0
From emergency contraception to migraines, advance supply can be appropriate. Here’s how to decide when it is – and isn’t.